Hair & Scalp · Treatments

Finasteride for hair loss: results, side effects and cost in India

A young man in a white T-shirt stands at a stone bathroom basin in soft daylight, holding a single white tablet up in one hand and a glass of water in the other, with a small supplement bottle and a folded towel on the counter beside him.
One tablet a day, for as long as you want the result. Finasteride suppresses a process rather than curing it, which makes the routine the treatment.

Finasteride is a prescription tablet for male pattern hair loss, sold as Propecia and, in India, as Finpecia, Finalo, Finax and many other brands. It blocks the enzyme that converts testosterone into DHT, the hormone that shrinks susceptible scalp follicles, and at 1 mg a day it cuts scalp DHT by about two-thirds. In trials it slowed hair fall in most men and regrew some hair in many. The benefit lasts only while you keep taking it.

In brief

  • Works by blocking type II 5-alpha-reductase; scalp DHT falls about 64% at 1 mg a day.1
  • Five-year trials: 65% of treated men had higher hair counts, 90% showed no further visible loss, 75% of placebo men got worse; endpoint populations varied.3
  • Sexual side effects: 3.8% vs 2.1% on placebo in year one; each listed event fell to 0.3% or below by year five.4
  • Benefit reverses within about 12 months of stopping. Not for women who are or may become pregnant.4
  • India: around ₹6.5 to ₹13 a tablet at current MRPs, roughly ₹200 to ₹400 for 30 tablets before pharmacy discounts, on prescription.11

In the trials that got finasteride approved, 3.8% of the men taking it reported a sexual side effect, against 2.1% of the men taking a dummy tablet. Those two numbers capture one important part of the argument about this drug. The difference is real, and it is much smaller than the online debate implies. Other questions, particularly mood effects and symptoms reported after stopping, come from different evidence and need weighing separately. This page gives you the numbers on every side, names what is unsettled, and explains what taking it looks like in India.

What is finasteride and how does it work? Copy link

Finasteride is a 5-alpha-reductase inhibitor. That enzyme comes in two types. The type II form converts testosterone into dihydrotestosterone, or DHT, in the scalp and the prostate. In men who are genetically susceptible, DHT binds to receptors in the follicles across the crown and mid-scalp. It shortens each growth cycle, so each replacement hair emerges a little finer than the one before it.

That process is what DHT does to a follicle, and it is the engine of male pattern baldness.

Finasteride blocks the enzyme, so less testosterone becomes DHT. The size of that effect has been measured directly. In a dose-ranging study, 249 men had scalp biopsies before and after six weeks of treatment. At 1 mg a day, scalp DHT fell by 64.1% and serum DHT by 71.4%, against a 13% fall in the scalp on placebo.1 Less DHT means less pressure on the follicle. It can then run a longer growth cycle and produce a thicker hair.

So finasteride does not grow hair in any direct sense. It removes the thing that was shrinking it. That is why the drug protects better than it restores, why the men who do best are the ones who start while there is still something to protect, and why it does nothing at all for hair fall that was never driven by DHT in the first place. Simple. Slow. Conditional.

One enzyme, blocked: how finasteride cuts DHT A bold geometric poster. Three large shapes run left to right: a yellow circle labelled testosterone, a violet ring labelled 5-alpha-reductase type II, and a coral circle labelled DHT, joined by thick arrows. A cobalt bar strikes through the violet ring, labelled finasteride 1 mg. Beneath, two wide bars show the measured fall in DHT at that dose: 64 per cent in scalp skin and 71 per cent in blood, against 13 per cent on placebo. No anatomy is drawn. PLATE 1 · SAPIENS One enzyme, blocked. TESTO- STERONE 5α-REDUCTASE TYPE II FINASTERIDE 1 MG BLOCKS IT DHT shrinks susceptible follicles DHT AT 1 MG A DAY · 6 WEEKS · 249 MEN scalp −64% placebo −13% blood −71% testosterone ↑ slightly Drake et al., J Am Acad Dermatol 1999 · a pathway, not a scalp
Plate 1 · Where the tablet acts. Testosterone becomes DHT through the type II 5-alpha-reductase enzyme; DHT shortens the growth cycle of susceptible follicles. Finasteride blocks the enzyme, and the measured effect at 1 mg a day is a 64% fall in scalp DHT and a 71% fall in serum DHT (Drake et al., 1999). A diagram of the pathway; no scalp is drawn.

Does finasteride work for hair loss? Copy link

Yes. In the five-year extension of its registration trials, two out of three men on finasteride had an increased hair count and nine out of ten showed no further visible loss on blinded photographs. Three out of four men on placebo were visibly worse.3 Very few hair treatments can point to large placebo-controlled trials with blinded photographic assessment; this is one that can.

The registration programme, sponsored by the manufacturer, ran three double-blind trials in 1,879 men, all aged 18 to 41, all with mild to moderate loss. Two of them, with 1,553 men, studied the vertex over two years; the third, with 326 men, studied the front of the scalp over one year.2

Both found finasteride 1 mg slowed progression and increased hair count against placebo. In the extension, hair counts in the treated group stayed above baseline throughout, ending at a net difference of 277 hairs in a 5.1 cm² circle of scalp.3

Read the five-year figures with their attrition in mind. As with most long-term extension studies, the population shrank over time: 1,215 men entered the extensions, 323 continuously treated men and 23 on placebo entered the fifth year, and the year-five hair-count analysis rested on 219 treated men against 15.4 The direction of the result is not in doubt. The precision of the year-five percentages is.

And read the second number carefully, because it matters more than the first. The headline benefit of finasteride is not a dramatic return of hair. It is that most men who take it are still holding what they had five years later, in a condition that otherwise only moves one way. Some regrowth on top of that is common. A full reversal is not.

Who does finasteride work best for? Copy link

Finasteride is best established in men with mild-to-moderate pattern loss who still have substantial miniaturised hair to preserve. Earlier-stage disease matters more reliably than age alone. Four things shape the response, and they all point the same direction.

Starting early. The trials enrolled men with mild to moderate loss, and that is the population the results describe. A follicle that still produces a visible hair can be protected. One that has been a vellus wisp for a decade has much less to work with.

Loss at the crown. The largest trials studied vertex thinning, and that is where the evidence is strongest. The frontal scalp was studied separately and also improved. The label is explicit that efficacy at the temples, the receding corners of the hairline, has not been established.4 Know that before you judge the drug by whether your hairline came back.

The right diagnosis. The drug treats DHT-driven pattern loss and nothing else. Diffuse shedding, thyroid disease, nutritional deficiency and inflammatory scalp disease need a different diagnosis and a different treatment, and no dose of finasteride will touch them.

Taking it consistently. Not a biological factor, but the commonest reason a course fails. A daily tablet works when it is taken daily.

How long does finasteride take to work? Copy link

Three months or more before any benefit can be seen, with the clearest window for judging it between six and twelve months.4 The hair cycle sets the pace, and, as you would expect, no drug speeds the cycle up.

What the response usually looks like
TimeframeWhat to expect
0 to 3 monthsUsually too early to judge visually.
3 to 6 monthsThe earliest stabilisation or improvement may become noticeable.
6 to 12 monthsA useful window for comparing standardised photographs and assessing response.
12 to 24 monthsHair-count gains in the long-term trials were greatest around this period before settling into maintenance.

Judge it at six and twelve months, with photographs taken in the same light, from the same angle, with the same parting, on a day when the hair has not just been washed or oiled, because every one of those things changes what a camera sees more than the drug will in its first month. Not before. Judging a hair drug at six weeks is like judging a monsoon by the first afternoon.

Does finasteride cause shedding at first? Copy link

Not in any way the trials documented. An early rise in shedding is well described for minoxidil, where the drug pushes resting follicles to release old hairs before growing new ones. For finasteride, no equivalent phase appears in the label or the registration trials, and the stories of a "dread shed" in the first months are reports, not data.

If your shedding does rise in the first three months, the likelier explanations are the loss you already had continuing on its own timetable, or a coincident telogen effluvium from a fever, a diet or a stressful season. An early shed is not an established finasteride effect. If shedding becomes marked or persistent, or the scalp is painful, inflamed or scaly, get it reviewed instead of assuming it is a normal treatment phase.

What happens if you stop taking finasteride? Copy link

DHT suppression ends and the loss resumes. The treatment effect is generally lost over the following months, and the prescribing information describes reversal within about twelve months of stopping.4 Finasteride suppresses a process; it does not cure it, and there is no course you complete.

That is the part worth sitting with before you start, because it is a commitment. A daily tablet, for as long as you want the result, taken through the years when the hair looks fine and there is no visible reason to bother. That is precisely when it is doing its work.

A man who takes it for two years, feels pleased, stops, and is surprised a year later has not had bad luck. He has had the expected outcome. Nothing more.

What are the side effects of finasteride? Copy link

In the pooled registration trials, 3.8% of the 945 men on finasteride reported one or more sexual adverse experiences, meaning reduced libido, erectile difficulty or an ejaculation problem, against 2.1% of the 934 men on placebo.4 That difference was statistically significant, and it is the legitimate basis for the concern.

The same label records two things that usually get left out. Symptoms resolved in men who stopped, and in most of the men who kept taking the drug. And the incidence of each of the listed sexual adverse events fell to 0.3% or below by the fifth year.4

Mood. Depression and suicidal ideation appear in the label's post-marketing section. European regulators went further in 2025. After a safety review, suicidal thinking was added as a recognised effect of the tablets, at a frequency the data cannot pin down, with most reports arising at the 1 mg hair dose.5 The instruction attached to it is to stop the medicine and get medical advice if depressed mood or thoughts of self-harm appear.

An Indian pack insert may not match a European one word for word, so read your own, and raise any shift in mood with your doctor early.

Persistent symptoms. Some men report sexual, mood or cognitive symptoms that continue after they stop, a cluster usually called post-finasteride syndrome. The label acknowledges post-marketing reports of sexual dysfunction continuing after discontinuation.4

Whether it is a distinct clinical entity, how often it occurs, and what causes it are genuinely unresolved. Reviews point out that the supporting studies are small and prone to selection bias, that a nocebo effect is plausible, and that the question deserves better research than it has had.6

Calling the syndrome proven overstates what exists; calling it imaginary dismisses men who are unwell. The position the evidence supports is that this risk cannot be quantified, which is itself a reason to make the decision deliberately. Rarer effects include breast tenderness or enlargement, which needs prompt review, and hypersensitivity reactions. Anything new and persistent belongs in front of your prescriber.

The trade, in numbers: what finasteride buys and what it risks A two-panel poster. The left panel, chartreuse, shows the five-year benefit: three circles scaled to 65, 90 and 75 per cent for higher hair count, no further visible loss, and placebo men visibly worse. The right panel, coral, shows risk: a circle scaled to 3.8 per cent for men reporting a sexual side effect beside a smaller circle for 2.1 per cent on placebo, and a dot for 0.3 per cent, the year-five incidence of each listed event. A black footer reads: the effect ends when the tablet ends. PLATE 2 · SAPIENS What it buys. five-year extension · endpoint populations varied 65% higher hair count 90% held the line 75% on placebo got worse net +277 hairs vs placebo in 5.1 cm² (219 vs 15 men) What it risks. pooled first-year trial data 3.8% sexual side effect 2.1% on placebo ≤0.3% each listed event, by year five most resolved, on stopping or continuing persistent symptoms: reported, unquantified The effect ends when the tablet ends. Propecia prescribing information · five-year study, Eur J Dermatol 2002 · circles scaled to value within each panel
Plate 2 · The trade, in numbers. Benefit and risk from the finasteride registration programme and its five-year extension, alongside the drug's central condition: the effect stops when the tablet stops. Circles are scaled to their values within each panel. Figures from the Propecia prescribing information and the five-year study; sexual adverse experiences are the pooled first-year rate against placebo, and the 0.3% figure is the year-five incidence of each listed event.

Does finasteride affect fertility or sperm? Copy link

Finasteride can affect semen parameters in some men, although the frequency and clinical importance are uncertain. In a study of healthy men on 1 mg for 48 weeks, ejaculate volume fell by a median of 0.3 mL, an 11% drop, against 0.2 mL, or 8%, on placebo.4 Post-marketing reports include male infertility and poor seminal quality, with improvement or normalisation reported after stopping; because these are spontaneous reports, their frequency cannot be estimated and causation cannot always be established.4

For a man starting finasteride in the years when marriage and children are being planned, this deserves a direct conversation. If conception is delayed, tell the fertility clinician you are taking finasteride. A semen analysis can assess sperm and semen parameters, and fertility is multifactorial, so the drug should be one variable on the list, not the whole answer.

Does finasteride lower testosterone? Copy link

No. It lowers DHT, and testosterone goes up slightly, because testosterone that is not being converted stays as testosterone. In the dose-ranging study, serum testosterone rose modestly while DHT fell by around 70%.1

This matters because the fear behind many online arguments is that finasteride "kills your testosterone", and it does the opposite to that particular number. Whatever explains the sexual side effects some men experience, a fall in circulating testosterone is not it. If you want a lab test to reassure you, testosterone is the wrong one to ask for.

How does finasteride affect the PSA test and prostate risk? Copy link

Finasteride lowers PSA, the blood marker used in prostate screening, even at the 1 mg hair-loss dose. In the Propecia trials, mean PSA fell from 0.7 to 0.5 ng/mL over twelve months in men aged 18 to 41. At the 5 mg prostate dose in older men, the reduction is roughly 50%.4

The practical consequence: a PSA that looks reassuring may not be, and a confirmed rise from your lowest reading while on the drug should be investigated even if the number is still in the normal range. Most men starting finasteride for hair in their twenties are years from PSA testing. The point is to remember, years from now, to tell whoever orders it. Put it on your medication list and leave it there.

On prostate cancer itself, the data come from the 5 mg dose. In a seven-year prevention trial in 18,882 men over 55, finasteride 5 mg reduced prostate cancer diagnoses overall but was associated with a higher rate of high-grade tumours: 1.8% against 1.1% on placebo.4 The label states that the clinical significance for men taking 1 mg is unknown.

The later story matters. Longer follow-up of that trial found similar overall survival at fifteen years in the two groups, 78.0% against 78.2%, and later analyses suggest that altered cancer detection may explain part of the high-grade difference.12 None of those data establishes an equivalent prostate-cancer risk from 1 mg hair-loss treatment, in either direction. The practical issue for a man taking finasteride remains the one above: PSA is lowered and must be interpreted with the medication in mind.

How do you take finasteride? Copy link

One 1 mg tablet a day, with or without food, at whatever time you will remember. If you miss a dose, take the next one at the usual time; do not double up. The label identifies no drug interactions of clinical importance and carries no warning about alcohol.4 Swallow the tablet whole and keep the strip intact; the film coating is what keeps the active ingredient off the hands of anyone who touches it.

That last point is the one house rule. Anyone pregnant, or who might be, must not handle a broken or crushed tablet, because the drug can affect the development of a male foetus. Store the strip where nobody else needs to touch it, and if a tablet crumbles, wash the contact area with soap and water.4

Should you take 1 mg or 5 mg? Copy link

One milligram, for hair. The 5 mg tablet is the prostate dose, and men sometimes assume it must work better on hair. The dose-ranging data say otherwise: scalp DHT fell 64.1% at 1 mg and 69.4% at 5 mg, and doses as low as 0.2 mg were already near the ceiling of what the enzyme block can achieve.1

The 5 mg dose suppresses scalp DHT only slightly further, and the dose-ranging efficacy trials, which randomised men to 0.01, 0.2, 1 or 5 mg, found 1 mg and 5 mg similarly effective for hair growth. That is why 1 mg became the standard hair-loss dose.13

Some patients use divided 5 mg tablets off-label for cost reasons. The drawbacks are dose accuracy and, more importantly, the pregnancy-handling hazard created once the coating is broken, because an intact coating is what keeps the active ingredient off the hands of anyone who touches the tablet.4 With inexpensive 1 mg generics widely available in India, use the formulation and dose prescribed to you.

Does topical finasteride work? Copy link

Yes, in the one phase III trial that tested it, with much lower systemic exposure than the tablet. The study randomised 458 men to a 0.25% finasteride spray, placebo, or oral finasteride for 24 weeks. Hair count in the target area rose by 20.2 against 6.7 with placebo, a result numerically similar to the oral arm. Peak blood levels were more than a hundred times lower, and serum DHT fell 34.5% against 55.6% with the tablet.7

That is a genuine finding and it comes with genuine limits. Systemic exposure is much lower, not zero. Pregnancy-related handling precautions still matter, while other safety warnings can differ by formulation and jurisdiction. The 2025 European review, for instance, found no evidence linking suicidal ideation to the finasteride skin spray while confirming it for the tablets.5

The trial ran 24 weeks, against five-year data for the tablet. And topical finasteride products in India vary in formulation and concentration, so a product on the shelf should not automatically be assumed equivalent to the specific spray formulation tested in the phase III trial. It is a reasonable conversation to have with a dermatologist before you buy anything.

Finasteride, minoxidil, or both? Copy link

For men with confirmed pattern hair loss, combination treatment is a reasonable option, and it outperformed either treatment alone in one randomised comparison. They are not competitors, because they work at different points. Finasteride reduces the hormonal signal that shrinks follicles. Minoxidil acts at the follicle to extend the growth phase, whatever caused the shortening.

In that comparison, clinician-rated improvement was reported in 59% of men on minoxidil alone, 80.5% on finasteride alone and 94.1% on both.8 The trial was open-label, so every arm reads high; the ranking is the finding and the percentages are soft. Dermatologists combine the two routinely.

If you would rather not take a tablet at all, minoxidil alone is a legitimate choice with real evidence behind it. What is not a legitimate substitute is a growth serum, a biotin supplement or an oil, none of which has evidence anywhere near this.

Is dutasteride better than finasteride? Copy link

At suppressing DHT and at 24-week hair counts, yes; as a first choice for a young man, not automatically. Dutasteride blocks both types of 5-alpha-reductase, where finasteride mainly blocks type II. A 2019 meta-analysis of head-to-head trials found it superior to finasteride on hair-count and photographic outcomes at 24 weeks, and regulators in Japan and South Korea have approved it for pattern hair loss.14,9

Finasteride has the broader long-term randomised evidence base for male pattern hair loss, so dutasteride is generally a treatment to discuss with a dermatologist after a fair trial of finasteride, and not an automatic stronger first choice. Its much longer half-life also means systemic drug exposure persists considerably longer after stopping.

Can women take finasteride? Copy link

Not as a standard treatment, and never in pregnancy or when pregnancy is possible. In the main placebo-controlled 1 mg trial, 137 post-menopausal women were treated for a year and no benefit was demonstrated on hair counts, photographs, investigator assessment or the women's own ratings.10

Uncontrolled series using larger doses report some responders, typically women who also show signs of androgen excess, which is a signal and not an established treatment. This is why female pattern hair loss is managed on a different first line, usually topical minoxidil.

The safety rule here is absolute. Finasteride can interfere with the development of the genitals of a male foetus, so a pregnancy, or the possibility of one, rules the drug out entirely, and it also rules out picking up a broken or powdered tablet. Keep the strip intact, keep it out of reach at home, and if one crumbles in the house, let someone else clear it up.

How much does finasteride cost in India, and which brand? Copy link

Around ₹6.5 to ₹13 per 1 mg tablet at current maximum retail prices for several common brands, or roughly ₹200 to ₹400 for 30 tablets before pharmacy discounts, and it needs a prescription. The common brands are Finpecia from Cipla, Finalo from Intas, Finax from Dr Reddy's and Finast from Torrent, among many others.11 Prices move, so treat that as the order of magnitude and check the current strip price at your pharmacy.

On brands: they contain the same active ingredient and strength; manufacturer, excipients, packaging and price differ. Buy from a licensed pharmacy instead of a marketplace listing, and be wary of combination products that bundle finasteride with other actives at concentrations nobody has tested.

One clinical point matters more than any brand comparison. Not every complaint of hair fall is androgenetic alopecia. Diffuse shedding, thyroid disease, nutritional deficiency and inflammatory scalp disease can require a different diagnosis and a different treatment, and the assessment that separates them is the reason the prescription exists.

Who should not take finasteride? Copy link

Any woman with a possible pregnancy, for the reason above. Children and adolescents, for whom it is not indicated. Anyone with a known hypersensitivity to it. Men with liver disease should have it discussed carefully, since the drug is metabolised there.

Beyond the contraindications, there are men for whom it is simply the wrong tool. Loss that is diffuse and unpatterned. Loss that followed an illness, a crash diet or a delivery by two to four months. A scalp that is inflamed, scaly, painful or scarred. In each case the diagnosis comes first, and a DHT blocker will not touch it.

And there is a legitimate personal reason to decline. If a small, poorly quantified risk of persistent side effects is going to sit badly with you for the next decade, that is a fair basis for turning down an elective long-term treatment for hair loss. Declining treatment after an informed discussion is a reasonable choice.

Transplants, beards and the long run Copy link

Three questions that arrive together. After a hair transplant, finasteride is commonly continued. The transplanted hair comes from the DHT-resistant back of the scalp, but the native hair around it is still susceptible, and without treatment it keeps thinning around a permanent island.

On beards and body hair, the registration trials recorded non-scalp hair growth as a secondary observation, and a change in beard growth is not an expected effect at 1 mg.4

On the long run: controlled hair-loss trials extend to five years. Longer observational follow-up exists, but it is much less capable of detecting or quantifying rare and persistent adverse effects. Long-term safety therefore rests on both the trial programme and continuing pharmacovigilance, which is what produced the 2025 mood warning.

When to involve a doctor Copy link

Before starting, ideally, because a five-minute examination establishes whether you have the condition the drug treats. Promptly if you develop sexual difficulty, low mood, breast tenderness or swelling, or any change that worries you; some effects settle and some warrant stopping, and that is a judgement for a prescriber.

And at the twelve-month mark if nothing has changed at all. That is when a dermatologist reassesses, and it is usually the point where men quietly give up instead.

Take the photographs before you start. Very few men do. The ones who did are the ones who can tell, a year later, whether the year was worth it. Take them.

Frequently asked questions Copy link

Does finasteride work for hair loss?

Yes, in men with pattern hair loss. In the five-year extension of its registration trials, two-thirds of treated men had an increased hair count and nine in ten showed no further visible loss on photographs, against three in four placebo men who got visibly worse. It protects better than it restores.

How long does finasteride take to work?

Three months or more before any benefit can be seen, with six to twelve months the useful window for judging it and hair counts peaking in the first two years. Judge it with photographs at six and twelve months instead of week to week.

What happens if I stop taking finasteride?

DHT suppression ends and the loss resumes. The prescribing information describes reversal of the treatment effect within about twelve months of stopping. The benefit lasts only while you take it.

How common are finasteride side effects?

In the registration trials, 3.8% of men on finasteride reported a sexual side effect against 2.1% on placebo, a real but small difference. Symptoms resolved in men who stopped and in most who continued, and the incidence of each listed sexual adverse event fell to 0.3% or below by the fifth year. Reports of persistent symptoms after stopping exist and remain unresolved in the research.

Does finasteride affect fertility?

It can affect semen parameters in some men, though how often and how much is uncertain. A small fall in semen volume was seen in trials, and post-marketing reports include poor seminal quality that improved after stopping. If conception is delayed, tell the fertility clinician you are taking it; a semen analysis can assess sperm and semen parameters, and fertility depends on many factors.

Does finasteride reduce testosterone?

No. It blocks the conversion of testosterone to DHT, so DHT falls sharply while testosterone rises slightly. Whatever explains the sexual side effects reported by some men, low testosterone is not the mechanism.

Should I take 1 mg or 5 mg?

One milligram is the hair dose. Five milligrams is the prostate dose, and dose-ranging data show doses at or above 0.2 mg already suppress scalp DHT close to maximally, so the larger tablet adds exposure without adding benefit. Do not split 5 mg tablets without discussing it with your prescriber, because a broken coating exposes the active ingredient.

Can finasteride and minoxidil be used together?

Yes, and combined treatment outperformed either alone in a randomised comparison. They work at different points, one on the hormone and one at the follicle, and dermatologists commonly prescribe them together.

Is topical finasteride safer than the tablet?

Systemic exposure is much lower, not zero, and a phase III trial found hair-count gains similar to the tablet at 24 weeks. Pregnancy-related handling precautions still apply, while other safety warnings can differ by formulation and jurisdiction, and most topical products sold in India are not the studied formulation.

How much does finasteride cost in India?

Around ₹6.5 to ₹13 per 1 mg tablet at current MRPs depending on brand, so roughly ₹200 to ₹400 for 30 tablets before discounts, on prescription. Common brands include Finpecia, Finalo, Finax and Finast; they contain the same active ingredient and strength, and differ in manufacturer, excipients, packaging and price. Check current prices, which change.

Can women take finasteride for hair loss?

Not in the standard way. In the main placebo-controlled trial, 137 post-menopausal women took 1 mg for a year and no benefit was demonstrated. The drug also must not be taken, or handled in broken form, by any woman who is or might become pregnant, because it can affect the development of a male foetus.

References Copy link

  1. Drake L, Hordinsky M, Fiedler V, et al. The effects of finasteride on scalp skin and serum androgen levels in men with androgenetic alopecia. J Am Acad Dermatol. 1999;41(4):550-554. PMID 10495374
  2. Kaufman KD, Olsen EA, Whiting D, et al. Finasteride in the treatment of men with androgenetic alopecia. J Am Acad Dermatol. 1998;39(4 Pt 1):578-589. doi:10.1016/S0190-9622(98)70007-6
  3. Finasteride Male Pattern Hair Loss Study Group. Long-term (5-year) multinational experience with finasteride 1 mg in the treatment of men with androgenetic alopecia. Eur J Dermatol. 2002;12(1):38-49. PMID 11809594
  4. Merck Sharp & Dohme. PROPECIA (finasteride) tablets, prescribing information. DailyMed, US National Library of Medicine. dailymed.nlm.nih.gov
  5. European Medicines Agency. Measures to minimise risk of suicidal thoughts with finasteride and dutasteride medicines. EMA/202053/2025; CMDh endorsement 19 June 2025. ema.europa.eu
  6. Cilio S, Tsampoukas G, Morgado A, Ramos P, Minhas S. Post-finasteride syndrome: a true clinical entity? Int J Impot Res. 2025. doi:10.1038/s41443-025-01025-6
  7. Piraccini BM, Blume-Peytavi U, Scarci F, et al. Efficacy and safety of topical finasteride spray solution for male androgenetic alopecia: a phase III, randomized, controlled clinical trial. J Eur Acad Dermatol Venereol. 2022;36(2):286-294. doi:10.1111/jdv.17738
  8. Hu R, Xu F, Sheng Y, et al. Combined treatment with oral finasteride and topical minoxidil in male androgenetic alopecia: a randomized and comparative study in Chinese patients. Dermatol Ther. 2015;28(5):303-308. doi:10.1111/dth.12246
  9. Ntshingila S, Oputu O, Arowolo AT, Khumalo NP. Androgenetic alopecia: an update. JAAD Int. 2023;13:150-158. doi:10.1016/j.jdin.2023.07.005
  10. Price VH, Roberts JL, Hordinsky M, et al. Lack of efficacy of finasteride in postmenopausal women with androgenetic alopecia. J Am Acad Dermatol. 2000;43(5 Pt 1):768-776. PMID 11050579
  11. Tata 1mg. Finalo 1 mg tablet (Intas), MRP ₹65.63 per 10; Finpecia 1 mg (Cipla), MRP ₹151.12 per 15; Finast 1 mg (Torrent), MRP ₹111.51 per 10; Finax 1 mg (Dr Reddy's), MRP ₹391.35 per 30. Product listings at 1mg.com, accessed 2 September 2026. MRPs change; pharmacy selling prices are usually lower.
  12. Thompson IM Jr, Goodman PJ, Tangen CM, et al. Long-term survival of participants in the Prostate Cancer Prevention Trial. N Engl J Med. 2013;369(7):603-610. doi:10.1056/NEJMoa1215932
  13. Roberts JL, Fiedler V, Imperato-McGinley J, et al. Clinical dose ranging studies with finasteride, a type 2 5alpha-reductase inhibitor, in men with male pattern hair loss. J Am Acad Dermatol. 1999;41(4):555-563. PMID 10495375
  14. Zhou Z, Song S, Gao Z, Wu J, Ma J, Cui Y. The efficacy and safety of dutasteride compared with finasteride in treating men with androgenetic alopecia: a systematic review and meta-analysis. Clin Interv Aging. 2019;14:399-406. doi:10.2147/CIA.S192435

This article is general health information for readers in India and is not a diagnosis or a prescription. Finasteride is a prescription medicine and this page does not tell you to take it, or what dose to take. A registered medical practitioner can confirm what is driving your hair loss, whether finasteride is appropriate for you, and how to weigh its risks against its benefits in your case. Written by Dr. Tarun Reddy, MBBS (registration TSMC/FMR/36195). Spotted an error? Report it and we will correct it.